Effect of Troglitazone on Expression of Adhesion Molecules and eNOS in Human Saphenous Vein Gaft
- Author:
Shu CHEN
1
;
Zhiwei HU
;
Kailun ZHANG
;
Wei SU
;
Zongquan SUN
Author Information
1. 华中科技大学同济医学院附属协和医院
- Keywords:
Troglitazone;
adhesion molecule;
endothelial nitric oxide synthase;
saphenous vein;
graft
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2007;27(6):657-659
- CountryChina
- Language:Chinese
-
Abstract:
To investigate whether peroxisome proliferators-activated receptor-y (PPARγ) ligand Troglitazone can reduce endothelial injury and activation during storage of harvested saphenous vein grafts. Segments of human saphenous vein graft were collected from 9 patients undergoing coronary bypass surgery and then divided into two equal parts of control and test specimens, were stored in ei-ther heparinized blood (control group) or heparinized blood containing 20 μmol/L troglitazone (test group) for 1 h at room temperature. Tissue distribution and protein expression of VCAM-1, ICAM-1, and endothelial nitric oxide synthase (eNOS) were compared using immunohistochemistry and West-ern blot analysis. Myeloperoxidase (MPO) activity, a marker of neutrophil sequestration in human saphenous vein grafts, was also measured in each group. The expression of ICAM-1 (753±132 versus 7201±934; P<0.01) , VCAM-1 (3731±294 versus 8292±793; P<0.01), and MPO activity (1.52±0.42 U/g, 5.04±1.26 U/g P<0.01) were significantly lower in test group. In contract, eNOS expression (7983±834 versus 3989±1008; P<0.01) was significantly higher in test group. PPARγ ligand troglita- zone might reduce endothelial injury during the storage period of human saphenous vein grafts.
